Intranasal Drug Delivery Device Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Drug delivery refers to the process of delivering a drug into the patient's body to have an effective therapeutic effect. Different modes are used for the delivery of the drug. Nasal and pulmonary routes are the most popular modes for delivering the drug. Intranasal delivery of drugs allows the drug to directly enter the brain by bypassing the BBB and avoids extensive hepatic and intestinal metabolism. This route has been a convenient and reliable route. Several new formulations are used to deliver drugs to the brain by olfactory, neuronal, and trigeminal pathways.
MARKET SCOPE
The Intranasal Drug Delivery Device Market is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Intranasal Drug Delivery Device Market with detailed market segmentation by type, material, end-user, and geography. The report provides key statistics on the market status of the leading Intranasal Drug Delivery Device Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on dosage form, the market is segmented into
I. Sprays
II. Drops & Liquids
III. Powders
IV. Gels
- By system, the market is segmented into
I. Multi-dose Systems
II. Bi-dose Systems
III. Unit-dose Systems
- Based on containers, the market is segmented into Pressurized containers and Non-pressurized Containers.
- On the basis of end-user, the market is segmented into Home Care Settings, Hospitals, and Others
MARKET DYNAMICS
Drivers:
- Increase in patient's preference for the nasal drug.
- Easy administration and better efficacy.
- Complications associated with the overuse of nasal spray.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South And Central America. The Intranasal Drug Delivery Device Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South And Central America after evaluating political, economic, social and technological factors affecting the Intranasal Drug Delivery Device Market in these regions.
IMPACT OF COVID-19 ON INTRANASAL DRUG DELIVERY DEVICE MARKET
COVID-19 first began in Wuhan (China) in December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has affected the growth of this market worldwide due to the business shutdown, worldwide lockdown, and supply and trade disruptions. While the situation is rapidly evolving, the pandemic had already disrupted the world in three ways the direct health impact the impact on the healthcare system, and the social and economic consequences of the pandemic. Patient visits to hospitals have been considerably reduced as a result of the lockdown in many nations. Surgeons do a battery of clinical tests before beginning interventional operations.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South And Central America. The Intranasal Drug Delivery Device Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South And Central America after evaluating political, economic, social and technological factors affecting the Intranasal Drug Delivery Device Market in these regions.
IMPACT OF COVID-19 ON INTRANASAL DRUG DELIVERY DEVICE MARKET
COVID-19 first began in Wuhan (China) in December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has affected the growth of this market worldwide due to the business shutdown, worldwide lockdown, and supply and trade disruptions. While the situation is rapidly evolving, the pandemic had already disrupted the world in three ways the direct health impact the impact on the healthcare system, and the social and economic consequences of the pandemic. Patient visits to hospitals have been considerably reduced as a result of the lockdown in many nations. Surgeons do a battery of clinical tests before beginning interventional operations.
MARKET PLAYERS
The report covers key developments in the Intranasal Drug Delivery Device Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships & collaborations. These activities have paved the way for the expansion of the business and customer base of market players. The market players in the Intranasal Drug Delivery Device Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Intranasal Drug Delivery devices Market in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Intranasal Drug Delivery Device Market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, and the key development in the past five years.
- Alza Corporation
- AstraZeneca PLC.
- Medimmune, Inc.,
- Baxter International, Inc.
- Becton
- Dickinson and Company
- GlaxoSmithKline Plc.
- Johnson & Johnson
- Aegis Therapeutics LLC
- Novartis AG
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Intranasal Drug Delivery Device Market - By Dosage Form
1.3.2 Intranasal Drug Delivery Device Market - By System
1.3.3 Intranasal Drug Delivery Device Market - By Containers
1.3.4 Intranasal Drug Delivery Device Market - By End-user
1.3.5 Intranasal Drug Delivery Device Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INTRANASAL DRUG DELIVERY DEVICE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INTRANASAL DRUG DELIVERY DEVICE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INTRANASAL DRUG DELIVERY DEVICE MARKET - GLOBAL MARKET ANALYSIS
6.1. INTRANASAL DRUG DELIVERY DEVICE - GLOBAL MARKET OVERVIEW
6.2. INTRANASAL DRUG DELIVERY DEVICE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. INTRANASAL DRUG DELIVERY DEVICE MARKET - REVENUE AND FORECASTS TO 2028 - DOSAGE FORM
7.1. OVERVIEW
7.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
7.3. SPRAYS
7.3.1. Overview
7.3.2. Sprays Market Forecast and Analysis
7.4. DROPS AND LIQUIDS
7.4.1. Overview
7.4.2. Drops and Liquids Market Forecast and Analysis
7.5. POWDERS
7.5.1. Overview
7.5.2. Powders Market Forecast and Analysis
7.6. GELS
7.6.1. Overview
7.6.2. Gels Market Forecast and Analysis
8. INTRANASAL DRUG DELIVERY DEVICE MARKET - REVENUE AND FORECASTS TO 2028 - SYSTEM
8.1. OVERVIEW
8.2. SYSTEM MARKET FORECASTS AND ANALYSIS
8.3. MULTI-DOSE SYSTEMS
8.3.1. Overview
8.3.2. Multi-dose Systems Market Forecast and Analysis
8.4. BI-DOSE SYSTEMS
8.4.1. Overview
8.4.2. Bi-dose Systems Market Forecast and Analysis
8.5. UNIT-DOSE SYSTEMS
8.5.1. Overview
8.5.2. Unit-dose Systems Market Forecast and Analysis
9. INTRANASAL DRUG DELIVERY DEVICE MARKET - REVENUE AND FORECASTS TO 2028 - CONTAINERS
9.1. OVERVIEW
9.2. CONTAINERS MARKET FORECASTS AND ANALYSIS
9.3. PRESSURIZED AND NON-PRESSURIZED CONTAINERS.
9.3.1. Overview
9.3.2. Pressurized and Non-pressurized containers. Market Forecast and Analysis
10. INTRANASAL DRUG DELIVERY DEVICE MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
10.1. OVERVIEW
10.2. END-USER MARKET FORECASTS AND ANALYSIS
10.3. HOME CARE SETTINGS
10.3.1. Overview
10.3.2. Home care settings Market Forecast and Analysis
10.4. HOSPITALS
10.4.1. Overview
10.4.2. Hospitals Market Forecast and Analysis
10.5. AND OTHERS.
10.5.1. Overview
10.5.2. and Others. Market Forecast and Analysis
11. INTRANASAL DRUG DELIVERY DEVICE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Intranasal Drug Delivery Device Market Overview
11.1.2 North America Intranasal Drug Delivery Device Market Forecasts and Analysis
11.1.3 North America Intranasal Drug Delivery Device Market Forecasts and Analysis - By Dosage Form
11.1.4 North America Intranasal Drug Delivery Device Market Forecasts and Analysis - By System
11.1.5 North America Intranasal Drug Delivery Device Market Forecasts and Analysis - By Containers
11.1.6 North America Intranasal Drug Delivery Device Market Forecasts and Analysis - By End-user
11.1.7 North America Intranasal Drug Delivery Device Market Forecasts and Analysis - By Countries
11.1.7.1 United States Intranasal Drug Delivery Device Market
11.1.7.1.1 United States Intranasal Drug Delivery Device Market by Dosage Form
11.1.7.1.2 United States Intranasal Drug Delivery Device Market by System
11.1.7.1.3 United States Intranasal Drug Delivery Device Market by Containers
11.1.7.1.4 United States Intranasal Drug Delivery Device Market by End-user
11.1.7.2 Canada Intranasal Drug Delivery Device Market
11.1.7.2.1 Canada Intranasal Drug Delivery Device Market by Dosage Form
11.1.7.2.2 Canada Intranasal Drug Delivery Device Market by System
11.1.7.2.3 Canada Intranasal Drug Delivery Device Market by Containers
11.1.7.2.4 Canada Intranasal Drug Delivery Device Market by End-user
11.1.7.3 Mexico Intranasal Drug Delivery Device Market
11.1.7.3.1 Mexico Intranasal Drug Delivery Device Market by Dosage Form
11.1.7.3.2 Mexico Intranasal Drug Delivery Device Market by System
11.1.7.3.3 Mexico Intranasal Drug Delivery Device Market by Containers
11.1.7.3.4 Mexico Intranasal Drug Delivery Device Market by End-user
11.2. EUROPE
11.2.1 Europe Intranasal Drug Delivery Device Market Overview
11.2.2 Europe Intranasal Drug Delivery Device Market Forecasts and Analysis
11.2.3 Europe Intranasal Drug Delivery Device Market Forecasts and Analysis - By Dosage Form
11.2.4 Europe Intranasal Drug Delivery Device Market Forecasts and Analysis - By System
11.2.5 Europe Intranasal Drug Delivery Device Market Forecasts and Analysis - By Containers
11.2.6 Europe Intranasal Drug Delivery Device Market Forecasts and Analysis - By End-user
11.2.7 Europe Intranasal Drug Delivery Device Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Intranasal Drug Delivery Device Market
11.2.7.1.1 Germany Intranasal Drug Delivery Device Market by Dosage Form
11.2.7.1.2 Germany Intranasal Drug Delivery Device Market by System
11.2.7.1.3 Germany Intranasal Drug Delivery Device Market by Containers
11.2.7.1.4 Germany Intranasal Drug Delivery Device Market by End-user
11.2.7.2 France Intranasal Drug Delivery Device Market
11.2.7.2.1 France Intranasal Drug Delivery Device Market by Dosage Form
11.2.7.2.2 France Intranasal Drug Delivery Device Market by System
11.2.7.2.3 France Intranasal Drug Delivery Device Market by Containers
11.2.7.2.4 France Intranasal Drug Delivery Device Market by End-user
11.2.7.3 Italy Intranasal Drug Delivery Device Market
11.2.7.3.1 Italy Intranasal Drug Delivery Device Market by Dosage Form
11.2.7.3.2 Italy Intranasal Drug Delivery Device Market by System
11.2.7.3.3 Italy Intranasal Drug Delivery Device Market by Containers
11.2.7.3.4 Italy Intranasal Drug Delivery Device Market by End-user
11.2.7.4 United Kingdom Intranasal Drug Delivery Device Market
11.2.7.4.1 United Kingdom Intranasal Drug Delivery Device Market by Dosage Form
11.2.7.4.2 United Kingdom Intranasal Drug Delivery Device Market by System
11.2.7.4.3 United Kingdom Intranasal Drug Delivery Device Market by Containers
11.2.7.4.4 United Kingdom Intranasal Drug Delivery Device Market by End-user
11.2.7.5 Russia Intranasal Drug Delivery Device Market
11.2.7.5.1 Russia Intranasal Drug Delivery Device Market by Dosage Form
11.2.7.5.2 Russia Intranasal Drug Delivery Device Market by System
11.2.7.5.3 Russia Intranasal Drug Delivery Device Market by Containers
11.2.7.5.4 Russia Intranasal Drug Delivery Device Market by End-user
11.2.7.6 Rest of Europe Intranasal Drug Delivery Device Market
11.2.7.6.1 Rest of Europe Intranasal Drug Delivery Device Market by Dosage Form
11.2.7.6.2 Rest of Europe Intranasal Drug Delivery Device Market by System
11.2.7.6.3 Rest of Europe Intranasal Drug Delivery Device Market by Containers
11.2.7.6.4 Rest of Europe Intranasal Drug Delivery Device Market by End-user
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Intranasal Drug Delivery Device Market Overview
11.3.2 Asia-Pacific Intranasal Drug Delivery Device Market Forecasts and Analysis
11.3.3 Asia-Pacific Intranasal Drug Delivery Device Market Forecasts and Analysis - By Dosage Form
11.3.4 Asia-Pacific Intranasal Drug Delivery Device Market Forecasts and Analysis - By System
11.3.5 Asia-Pacific Intranasal Drug Delivery Device Market Forecasts and Analysis - By Containers
11.3.6 Asia-Pacific Intranasal Drug Delivery Device Market Forecasts and Analysis - By End-user
11.3.7 Asia-Pacific Intranasal Drug Delivery Device Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Intranasal Drug Delivery Device Market
11.3.7.1.1 Australia Intranasal Drug Delivery Device Market by Dosage Form
11.3.7.1.2 Australia Intranasal Drug Delivery Device Market by System
11.3.7.1.3 Australia Intranasal Drug Delivery Device Market by Containers
11.3.7.1.4 Australia Intranasal Drug Delivery Device Market by End-user
11.3.7.2 China Intranasal Drug Delivery Device Market
11.3.7.2.1 China Intranasal Drug Delivery Device Market by Dosage Form
11.3.7.2.2 China Intranasal Drug Delivery Device Market by System
11.3.7.2.3 China Intranasal Drug Delivery Device Market by Containers
11.3.7.2.4 China Intranasal Drug Delivery Device Market by End-user
11.3.7.3 India Intranasal Drug Delivery Device Market
11.3.7.3.1 India Intranasal Drug Delivery Device Market by Dosage Form
11.3.7.3.2 India Intranasal Drug Delivery Device Market by System
11.3.7.3.3 India Intranasal Drug Delivery Device Market by Containers
11.3.7.3.4 India Intranasal Drug Delivery Device Market by End-user
11.3.7.4 Japan Intranasal Drug Delivery Device Market
11.3.7.4.1 Japan Intranasal Drug Delivery Device Market by Dosage Form
11.3.7.4.2 Japan Intranasal Drug Delivery Device Market by System
11.3.7.4.3 Japan Intranasal Drug Delivery Device Market by Containers
11.3.7.4.4 Japan Intranasal Drug Delivery Device Market by End-user
11.3.7.5 South Korea Intranasal Drug Delivery Device Market
11.3.7.5.1 South Korea Intranasal Drug Delivery Device Market by Dosage Form
11.3.7.5.2 South Korea Intranasal Drug Delivery Device Market by System
11.3.7.5.3 South Korea Intranasal Drug Delivery Device Market by Containers
11.3.7.5.4 South Korea Intranasal Drug Delivery Device Market by End-user
11.3.7.6 Rest of Asia-Pacific Intranasal Drug Delivery Device Market
11.3.7.6.1 Rest of Asia-Pacific Intranasal Drug Delivery Device Market by Dosage Form
11.3.7.6.2 Rest of Asia-Pacific Intranasal Drug Delivery Device Market by System
11.3.7.6.3 Rest of Asia-Pacific Intranasal Drug Delivery Device Market by Containers
11.3.7.6.4 Rest of Asia-Pacific Intranasal Drug Delivery Device Market by End-user
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Intranasal Drug Delivery Device Market Overview
11.4.2 Middle East and Africa Intranasal Drug Delivery Device Market Forecasts and Analysis
11.4.3 Middle East and Africa Intranasal Drug Delivery Device Market Forecasts and Analysis - By Dosage Form
11.4.4 Middle East and Africa Intranasal Drug Delivery Device Market Forecasts and Analysis - By System
11.4.5 Middle East and Africa Intranasal Drug Delivery Device Market Forecasts and Analysis - By Containers
11.4.6 Middle East and Africa Intranasal Drug Delivery Device Market Forecasts and Analysis - By End-user
11.4.7 Middle East and Africa Intranasal Drug Delivery Device Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Intranasal Drug Delivery Device Market
11.4.7.1.1 South Africa Intranasal Drug Delivery Device Market by Dosage Form
11.4.7.1.2 South Africa Intranasal Drug Delivery Device Market by System
11.4.7.1.3 South Africa Intranasal Drug Delivery Device Market by Containers
11.4.7.1.4 South Africa Intranasal Drug Delivery Device Market by End-user
11.4.7.2 Saudi Arabia Intranasal Drug Delivery Device Market
11.4.7.2.1 Saudi Arabia Intranasal Drug Delivery Device Market by Dosage Form
11.4.7.2.2 Saudi Arabia Intranasal Drug Delivery Device Market by System
11.4.7.2.3 Saudi Arabia Intranasal Drug Delivery Device Market by Containers
11.4.7.2.4 Saudi Arabia Intranasal Drug Delivery Device Market by End-user
11.4.7.3 U.A.E Intranasal Drug Delivery Device Market
11.4.7.3.1 U.A.E Intranasal Drug Delivery Device Market by Dosage Form
11.4.7.3.2 U.A.E Intranasal Drug Delivery Device Market by System
11.4.7.3.3 U.A.E Intranasal Drug Delivery Device Market by Containers
11.4.7.3.4 U.A.E Intranasal Drug Delivery Device Market by End-user
11.4.7.4 Rest of Middle East and Africa Intranasal Drug Delivery Device Market
11.4.7.4.1 Rest of Middle East and Africa Intranasal Drug Delivery Device Market by Dosage Form
11.4.7.4.2 Rest of Middle East and Africa Intranasal Drug Delivery Device Market by System
11.4.7.4.3 Rest of Middle East and Africa Intranasal Drug Delivery Device Market by Containers
11.4.7.4.4 Rest of Middle East and Africa Intranasal Drug Delivery Device Market by End-user
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Intranasal Drug Delivery Device Market Overview
11.5.2 South and Central America Intranasal Drug Delivery Device Market Forecasts and Analysis
11.5.3 South and Central America Intranasal Drug Delivery Device Market Forecasts and Analysis - By Dosage Form
11.5.4 South and Central America Intranasal Drug Delivery Device Market Forecasts and Analysis - By System
11.5.5 South and Central America Intranasal Drug Delivery Device Market Forecasts and Analysis - By Containers
11.5.6 South and Central America Intranasal Drug Delivery Device Market Forecasts and Analysis - By End-user
11.5.7 South and Central America Intranasal Drug Delivery Device Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Intranasal Drug Delivery Device Market
11.5.7.1.1 Brazil Intranasal Drug Delivery Device Market by Dosage Form
11.5.7.1.2 Brazil Intranasal Drug Delivery Device Market by System
11.5.7.1.3 Brazil Intranasal Drug Delivery Device Market by Containers
11.5.7.1.4 Brazil Intranasal Drug Delivery Device Market by End-user
11.5.7.2 Argentina Intranasal Drug Delivery Device Market
11.5.7.2.1 Argentina Intranasal Drug Delivery Device Market by Dosage Form
11.5.7.2.2 Argentina Intranasal Drug Delivery Device Market by System
11.5.7.2.3 Argentina Intranasal Drug Delivery Device Market by Containers
11.5.7.2.4 Argentina Intranasal Drug Delivery Device Market by End-user
11.5.7.3 Rest of South and Central America Intranasal Drug Delivery Device Market
11.5.7.3.1 Rest of South and Central America Intranasal Drug Delivery Device Market by Dosage Form
11.5.7.3.2 Rest of South and Central America Intranasal Drug Delivery Device Market by System
11.5.7.3.3 Rest of South and Central America Intranasal Drug Delivery Device Market by Containers
11.5.7.3.4 Rest of South and Central America Intranasal Drug Delivery Device Market by End-user
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INTRANASAL DRUG DELIVERY DEVICE MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. INTRANASAL DRUG DELIVERY DEVICE MARKET, KEY COMPANY PROFILES
14.1. ALZA CORPORATION
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ASTRAZENECA PLC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. MEDIMMUNE, INC.,
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BAXTER INTERNATIONAL, INC.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. BECTON
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. DICKINSON AND COMPANY
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. GLAXO SMITHKLINE PLC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. JOHNSON AND JOHNSON
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. AEGIS THERAPEUTICS LLC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. NOVARTIS AG
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Alza Corporation
2. AstraZeneca PLC.
3. Medimmune, Inc.,
4. Baxter International, Inc.
5. Becton
6. Dickinson and Company
7. GlaxoSmithKline Plc.
8. Johnson & Johnson
9. Aegis Therapeutics LLC
10. Novartis AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For